Brown, Paul D.

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Gilbert, M. R., Dignam, J. J., Armstrong, T. S., Wefel, J. S., Blumenthal, D. T., Vogelbaum, M. A., Colman, H., Chakravarti, A., Pugh, S., Won, M., et al. (2014) · New England Journal of Medicine

Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer

Cited by 2,834

Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases

Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., et al. (2012) · Journal of Clinical Oncology

Brain Metastases and TreatmentManagement of metastatic bone disease

Cited by 1,425

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

Buckner, J. C., Shaw, E. G., Pugh, S. L., Chakravarti, A., Gilbert, M. R., Barger, G. R., Coons, S., Ricci, P., Bullard, D., Brown, P. D., et al. (2016) · New England Journal of Medicine

Glioma Diagnosis and TreatmentOvarian cancer diagnosis and treatment

Cited by 1,064

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

Gilbert, M. R., Wang, M., Aldape, K. D., Stupp, R., Hegi, M. E., Jaeckle, K. A., Armstrong, T. S., Wefel, J. S., Won, M., Blumenthal, D. T., et al. (2013) · Journal of Clinical Oncology

Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy

Cited by 1,063

Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

Sarkaria, J. N., Hu, L. S., Parney, I. F., Pafundi, D. H., Brinkmann, D. H., Laack, N. N., Giannini, C., Burns, T. C., Kizilbash, S. H., Laramy, J. K., et al. (2018) · Neuro-Oncology

Barrier Structure and Function StudiesGlioma Diagnosis and Treatment

Cited by 746

Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer

Welsh, J. W., Komaki, R., Amini, A., Munsell, M. F., Unger, W., Allen, P. K., Chang, J. Y., Wefel, J. S., McGovern, S. L., Garland, L. L., et al. (2013) · Journal of Clinical Oncology

Brain Metastases and TreatmentLung Cancer Treatments and Mutations

Cited by 395

Impacting quality of life for patients with advanced cancer with a structured multidisciplinary intervention: a randomized controlled trial

Rummans, T. A., Clark, M. M., Sloan, J. A., Frost, M. H., Bostwick, J. M., Atherton, P. J., Johnson, M. E., Gamble, G., Richardson, J., Brown, P., et al. (2006) · Journal of Clinical Oncology

Cancer survivorship and carePalliative and Oncologic Care

Cited by 353

Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response

Sarkaria, J. N., Carlson, B. L., Schroeder, M. A., Grogan, P., Brown, P. D., Giannini, C., Ballman, K. V., Kitange, G. J., Guha, A., Pandita, A., et al. (2006) · Clinical Cancer Research

Glioma Diagnosis and TreatmentCancer, Hypoxia, and Metabolism

Cited by 270

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma

Bell, E. H., Zhang, P., Shaw, E. G., Buckner, J. C., Barger, G. R., Bullard, D. E., Mehta, M. P., Gilbert, M. R., Brown, P. D., Stelzer, K. J., et al. (2020) · Journal of Clinical Oncology

Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research

Cited by 219

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

Brastianos, P. K., Twohy, E., Geyer, S., Gerstner, E. R., Kaufmann, T. J., Tabrizi, S., Kabat, B., Thierauf, J., Ruff, M. W., Bota, D. A., et al. (2023) · New England Journal of Medicine

Pituitary Gland Disorders and TreatmentsNeuroendocrine Tumor Research Advances

Cited by 146

CODEL: Phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Jaeckle, K. A., Ballman, K. V., van den Bent, M., Giannini, C., Galanis, E., Brown, P. D., Jenkins, R. B., Cairncross, J. G., Wick, W., Weller, M., et al. (2021) · Neuro-Oncology

Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy

Cited by 119

Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer

Clark, M. M., Rummans, T. A., Atherton, P. J., Cheville, A. L., Johnson, M. E., Frost, M. H., Miller, J. J., Sloan, J. A., Graszer, K. M., Haas, J. G., et al. (2013) · Cancer

Cancer survivorship and carePalliative and Oncologic Care

Cited by 115

RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM).

Gilbert, M. R., Dignam, J., Won, M., Blumenthal, D. T., Vogelbaum, M. A., Aldape, K. D., Colman, H., Chakravarti, A., Jeraj, R., Armstrong, T. S., et al. (2013) · Journal of Clinical Oncology

Glioma Diagnosis and TreatmentAngiogenesis and VEGF in Cancer

Cited by 70

Improving the quality of life of geriatric cancer patients with a structured multidisciplinary intervention: A randomized controlled trial

LAPID, M. I., RUMMANS, BROWN, P. D., FROST, M. H., JOHNSON, M. E., HUSCHKA, M. M., SLOAN, J. A., RICHARDSON, J. W., HANSON, J. M., & CLARK, M. M. (2007) · Palliative and Supportive Care

Cancer survivorship and careFrailty in Older Adults

Cited by 51

Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study

Mehta, M. P., Gondi, V., Ahluwalia, M. S., Roberge, D., Sio, T. T. W., Trifiletti, D. M., Muanza, T., Krpan, A. M., Zhu, Z., Ramakrishna, N. R., et al. (2026) · International Journal of Radiation Oncology*Biology*Physics

Brain Metastases and TreatmentGlioma Diagnosis and Treatment

Cited by 9